Orbital Therapeutics
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
About Orbital Therapeutics
Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. To produce an extended portfolio of medications, the company is developing an innovative platform at the confluence of RNA technology, delivery techniques, data analytics, and automation.
Company Facts
- Headquarters
- Cambridge
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- m_and_a
- Total Funding
- $270,000,000
- Last Funding Type
- series_a
- Last Funding Date
- 2023-04-26
- Website
- orbitaltx.com
Industries & Categories
Alternative Medicine, Biotechnology, Life Science, Therapeutics
Social Links
Canonical: https://fsome.com/organization/orbital-therapeutics-51044 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.